Business Standard

Gsk Pfizer

GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion

Lawsuits against the companies began piling up in both state and federal courts after the US Food and Drug Administration in 2020 asked manufacturers to pull Zantac off the market

GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion
Updated On : 10 Oct 2024 | 1:18 PM IST

Pfizer agrees to pay $93 million to settle Lipitor drug antitrust lawsuit

Pfizer introduced Lipitor in 1997, and the drug drove more than $130 billion in sales during its first 14 years on the market

Pfizer agrees to pay $93 million to settle Lipitor drug antitrust lawsuit
Updated On : 15 Feb 2024 | 7:59 AM IST

GSK backs out of $20 bn bidding race for Pfizer's consumer health-care unit

Pfizer is the world's fifth-largest player in consumer health with 2.5 percent of a market bolstered by ageing populations and growing interest in health and wellness

GSK backs out of $20 bn bidding race for Pfizer's consumer health-care unit
Updated On : 23 Mar 2018 | 8:19 PM IST